6 Views
top of page
Tech Talk
Public·8 members
All topics
Airbus (0)
Airworthiness Directives (0)
APU (0)
Boeing (0)
Dehavilland (0)
Embraer (0)
Landing Gear (0)
Powerplant (0)
Structures (0)
Systems (0)
⏱️ Diagnosis at the Doorstep: Europe’s Point-of-Care Testing Revolution! 💶🩺
Imagine receiving your critical lab results in 10 minutes directly at your local pharmacy or doctor’s office instead of waiting days for a central laboratory report! Point-of-Care Testing (POCT) is transforming European healthcare by delivering rapid, lab-quality diagnostics right where the patient is.
⏳ HISTORY & ORIGIN
The roots of POCT trace back to simple urine dipstick tests in the mid-20th century, followed by the breakthrough release of home blood glucose monitors in the 1970s.
Across Europe, the adoption of "near-patient testing" accelerated sharply in response to aging populations and rising chronic conditions. The COVID-19 pandemic further revolutionized European public health by normalizing rapid antigen and molecular testing outside traditional hospital settings. Today, European POCT standards are governed by the strict EU In Vitro Diagnostic Regulation (IVDR 2017/746), ensuring near-patient diagnostic devices meet uncompromising safety, usability, and clinical accuracy standards before reaching patients.
📂 THE CORE CATEGORIES OF POCT IN EUROPE
6 Views
🧬 The Living Medicine Revolution: How Cell Therapy Is Rewriting Medicine! 🔬✨
Imagine treating severe illnesses not with daily chemical pills or radiation, but with custom-engineered living human cells programmed to repair, replace, or fight disease from within! Welcome to cell therapy—the frontier of regenerative medicine.
⏳ HISTORY & ORIGIN
The foundation of modern cell therapy traces back to 1957, when Dr. E. Donnall Thomas performed the first successful human bone marrow transplant—transferring blood-forming stem cells to treat leukemia patients (a breakthrough that earned him a Nobel Prize in 1990).
Over the decades, bone marrow transplants paved the way for advanced cellular engineering. In the 2010s, researchers unlocked genetic modification tools, giving birth to CAR-T cell therapy. For the first time, scientists could extract a patient's own immune cells, rewrite their DNA in a laboratory to target cancer, and re-infuse them as targeted "living drugs".
📂 THE CORE TYPES OF CELL THERAPY
2 Views
🧬 Bio-Revolutions Beyond the Cell: The Rise of Next-Generation Biomanufacturing! 🔬⚡
What if we could produce life-saving biopharmaceuticals, synthetic enzymes, and eco-friendly biomaterials in hours instead of weeks—without relying on living cell growth? Welcome to the frontier of next-generation biomanufacturing!
⏳ HISTORY & ORIGIN
Traditional biomanufacturing has relied for over half a century on living host organisms—like Chinese Hamster Ovary (CHO) cells and E. coli bacteria—grown in massive stainless-steel bioreactors. While effective, cell-based batch processing is notoriously slow, costly, and vulnerable to contamination or cellular toxicity.
The roots of next-generation biomanufacturing began in 1961 when scientists first used cell-free extracts to crack the genetic code. Over the past decade, rapid advancements in synthetic biology, AI-driven pathway design, and continuous bioprocessing transformed these lab tools into flexible, industrial-scale biomanufacturing platforms.
📂 THE CORE CATEGORIES OF NEXT-GEN BIOMANUFACTURING
2 Views
Members
Tony Robbins
Tony Robbins
bottom of page